IL130967A0 - Freeze-dried composition of bone morphogenetic protein human mp52 - Google Patents
Freeze-dried composition of bone morphogenetic protein human mp52Info
- Publication number
- IL130967A0 IL130967A0 IL13096798A IL13096798A IL130967A0 IL 130967 A0 IL130967 A0 IL 130967A0 IL 13096798 A IL13096798 A IL 13096798A IL 13096798 A IL13096798 A IL 13096798A IL 130967 A0 IL130967 A0 IL 130967A0
- Authority
- IL
- Israel
- Prior art keywords
- freeze
- bone morphogenetic
- morphogenetic protein
- dried composition
- protein human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1634997 | 1997-01-30 | ||
PCT/JP1998/000371 WO1998033514A1 (fr) | 1997-01-30 | 1998-01-29 | Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses |
Publications (1)
Publication Number | Publication Date |
---|---|
IL130967A0 true IL130967A0 (en) | 2001-01-28 |
Family
ID=11913900
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13096798A IL130967A0 (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human mp52 |
IL130967A IL130967A (en) | 1997-01-30 | 1999-07-15 | Freeze-dried preparation of human morphogenetic MP52 bone protein |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL130967A IL130967A (en) | 1997-01-30 | 1999-07-15 | Freeze-dried preparation of human morphogenetic MP52 bone protein |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0972520B9 (sr) |
JP (1) | JP4209948B2 (sr) |
KR (1) | KR100548107B1 (sr) |
CN (1) | CN1152712C (sr) |
AP (1) | AP983A (sr) |
AT (1) | ATE302021T1 (sr) |
AU (1) | AU737595B2 (sr) |
BR (1) | BR9807537B1 (sr) |
CA (1) | CA2278546C (sr) |
DE (1) | DE69831223T9 (sr) |
DK (1) | DK0972520T3 (sr) |
EA (1) | EA001579B1 (sr) |
ES (1) | ES2244043T3 (sr) |
HU (1) | HU226554B1 (sr) |
IL (2) | IL130967A0 (sr) |
NO (1) | NO322334B1 (sr) |
NZ (1) | NZ336509A (sr) |
PL (1) | PL189381B1 (sr) |
RS (1) | RS49691B (sr) |
SI (1) | SI0972520T1 (sr) |
TR (1) | TR199901832T2 (sr) |
WO (1) | WO1998033514A1 (sr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4388602B2 (ja) † | 1997-02-07 | 2009-12-24 | ストライカー コーポレイション | マトリクスを含まない骨形成デバイス、移植片、およびその使用方法 |
WO2003030873A1 (en) * | 2001-10-09 | 2003-04-17 | Cellfactors Plc | Therapeutic biological product and method for formation of new vascularised bone |
CA2466947C (en) | 2001-11-19 | 2012-05-22 | Scil Technology Gmbh | A homogeneously coated device having osteoinductive and osteoconductive properties |
ATE322916T1 (de) | 2002-09-10 | 2006-04-15 | Scil Technology Gmbh | Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat |
EP1651272A1 (en) * | 2003-08-05 | 2006-05-03 | Fuji Photo Film B.V. | Use of recombinant or synthetic gelatin as a stabiliser in vaccines |
CA2545458A1 (en) * | 2003-11-10 | 2005-05-26 | Arriva-Prometic Inc. | Dry recombinant human alpha 1-antitrypsin formulation |
JP4944010B2 (ja) | 2004-03-10 | 2012-05-30 | サイル テクノロジー ゲーエムベーハー | コーティングされたインプラント、その製造および使用 |
US10360287B2 (en) | 2015-05-22 | 2019-07-23 | Microsoft Technology Licensing, Llc | Unified messaging platform and interface for providing user callouts |
US20160344677A1 (en) | 2015-05-22 | 2016-11-24 | Microsoft Technology Licensing, Llc | Unified messaging platform for providing interactive semantic objects |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3273597D1 (en) * | 1981-11-28 | 1986-11-06 | Sunstar Kk | Pharmaceutical composition containing interferon in stable state |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
AU663328B2 (en) * | 1991-06-21 | 1995-10-05 | Genetics Institute, Llc | Pharmaceutical formulations of osteogenic proteins |
JP2966592B2 (ja) * | 1991-07-20 | 1999-10-25 | 萩原 義秀 | 安定化されたヒトモノクローナル抗体製剤 |
UA48105C2 (uk) * | 1992-02-12 | 2002-08-15 | Біофарм Гезельшафт Цур Біотехнологішен Ентвіклунг Вон Фармака Мбх | ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ) |
CA2093836A1 (en) * | 1992-04-24 | 1993-10-25 | Wayne Gombotz | Biodegradable tgf-.beta. delivery system for bone regeneration |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
EP0814841B1 (en) * | 1995-03-21 | 2001-12-05 | Applied Research Systems ARS Holding N.V. | Hcg liquid formulations |
US7235527B2 (en) * | 1995-04-19 | 2007-06-26 | Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh | Protein and process for producing the same |
-
1998
- 1998-01-29 PL PL98334852A patent/PL189381B1/pl not_active IP Right Cessation
- 1998-01-29 AP APAP/P/1999/001602A patent/AP983A/en active
- 1998-01-29 AU AU56791/98A patent/AU737595B2/en not_active Ceased
- 1998-01-29 EA EA199900694A patent/EA001579B1/ru not_active IP Right Cessation
- 1998-01-29 IL IL13096798A patent/IL130967A0/xx active IP Right Grant
- 1998-01-29 BR BRPI9807537-3A patent/BR9807537B1/pt not_active IP Right Cessation
- 1998-01-29 NZ NZ336509A patent/NZ336509A/xx not_active IP Right Cessation
- 1998-01-29 DK DK98901044T patent/DK0972520T3/da active
- 1998-01-29 WO PCT/JP1998/000371 patent/WO1998033514A1/ja active IP Right Grant
- 1998-01-29 AT AT98901044T patent/ATE302021T1/de active
- 1998-01-29 HU HU0002386A patent/HU226554B1/hu not_active IP Right Cessation
- 1998-01-29 JP JP53271798A patent/JP4209948B2/ja not_active Expired - Fee Related
- 1998-01-29 EP EP98901044A patent/EP0972520B9/en not_active Expired - Lifetime
- 1998-01-29 KR KR1019997006833A patent/KR100548107B1/ko not_active IP Right Cessation
- 1998-01-29 RS YUP-349/99A patent/RS49691B/sr unknown
- 1998-01-29 SI SI9830798T patent/SI0972520T1/sl unknown
- 1998-01-29 ES ES98901044T patent/ES2244043T3/es not_active Expired - Lifetime
- 1998-01-29 CA CA002278546A patent/CA2278546C/en not_active Expired - Fee Related
- 1998-01-29 DE DE69831223T patent/DE69831223T9/de active Active
- 1998-01-29 CN CNB988019841A patent/CN1152712C/zh not_active Expired - Fee Related
- 1998-01-29 TR TR1999/01832T patent/TR199901832T2/xx unknown
-
1999
- 1999-07-15 IL IL130967A patent/IL130967A/en not_active IP Right Cessation
- 1999-07-29 NO NO19993702A patent/NO322334B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3866097A (en) | Naphtholactams and lactones as bone morphogenetic protein active agents | |
EG22500A (en) | Use of an encapsulated bioactive composition | |
HUP9902187A3 (en) | Diaphysial cortical dowel | |
EP1047442A4 (en) | BONE MORPHOGENETIC PROTEINS AND THEIR USE IN BONE GROWTH | |
ZA989461B (en) | Methods and compositions for the treatment of autoimmune disease using heat shock proteins | |
HUP9802556A3 (en) | Use of bone morphogenetic protein (bmp) for regeneration of functional connection of bone and tendon or ligament | |
EP1039801A4 (en) | 207 HUMAN SECRETED PROTEINS | |
PL339463A1 (en) | April - novel protein of growth promoting action | |
EP1000084A4 (en) | 123 PROTEIN SEPARATED BY HUMAN | |
EP0975371A4 (en) | ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS AND METHOD FOR MODULATING THE ACTIVATING PROTEIN 1. | |
EP1095159A4 (en) | Bone Morphogenetic Protein | |
EP1040117A4 (en) | 110 HUMAN SECRETATED PROTEINS | |
EP1019091A4 (en) | 50 SECRETED PROTEINS OF HUMAN ORIGIN | |
EP1005544A4 (en) | 70 HUMAN, SECRETED PROTEINS | |
HUP9603373A3 (en) | Cosmetic composition for artificial tanning and its use | |
IL130967A0 (en) | Freeze-dried composition of bone morphogenetic protein human mp52 | |
EP1027430A4 (en) | SERIES OF 64 HUMAN SECRETED PROTEINS | |
EP1032838A4 (en) | 125 HUMAN SECRETED PROTEINS | |
AU7115996A (en) | Uses of bone morphogenetic proteins | |
EP1009766A4 (en) | 19 HUMAN, SECRETED PROTEINS | |
AU6245898A (en) | Injectable formulations for treatment of osteoporotic bone | |
EP1042674A4 (en) | 148 HUMAN SUCKED PROTEINS | |
EP0691349A3 (en) | Morphogenetic dimeric proteins of bone origin and their fragments and anologues and pharmaceutical compositions containing them | |
EP1017707A4 (en) | 29 HUMAN SECRETED PROTEINS | |
EP1003763A4 (en) | 83 HUMAN SECRETED PROTEINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
FF | Patent granted | ||
KB | Patent renewed |